Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: WuXi PharmaTech 3Q10 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: WuXi PharmaTech 3Q10

Growth in the quarter was attributed to growth in Lab Services and Manufacturing Services.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech 3Q10

3Q Revenues: $83.8 million (+20%)

3Q Earnings: $44.3 million (+209%)

YTD Revenues: $245.5 million (+25%)

YTD Earnings: $73.5 million (+80%)

Comments: Growth in the quarter was attributed to growth in Lab Services and Manufacturing Services. China-based Lab Services revenues were up 19% in the quarter to $57.1 million. U.S Lab Services revenues increased 20% to $19.6 million. Manufacturing revenues were $7.1 million (+23%).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters